Konstam was guest author for Merck
Links shared publicly online about this topic.
- 2,077total visits
Konstam was guest author for Merck
Prominent cardiologist Dr Marvin Konstam agreed to be lead author on a 2001 Circulation paper about the COX-2 inhibitor rofecoxib, which was written in-house by Merck scientists, according to claims made in a federal court in Australia last week.
View full resource at theheart.org
Tags: Circulation, COX-2 Inhibitor, Vioxx, Merck & Co., Cardiologist, Scientist, Cardiology
Most Recently Shared on April 30, 2009 at 10:01 pm By:
heartwire: Fresh questions raised about prominent cardiologist's role in "ghostwritten" 2001 meta-anal.. http://bit.ly/18m4Dz
Advertisement
